MarketCap
Facebook
X
TelegramQuarterly report 2024-Q1
added 05-17-2024
ThermoGenesis Holdings Cash Flow 2011-2026 | THMO
Annual Cash Flow ThermoGenesis Holdings
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-7.28 M | -6.62 M | -14.4 M | -3.26 M | -6.98 M | -7.22 M | -9.62 M | -10.6 M | -7.84 M | -3.08 M | -3.88 M | -2.09 M |
Depreciation & Amortization |
926 K | 633 K | 742 K | 805 K | 670 K | 830 K | 1.17 M | 1.35 M | 993 K | 538 K | 604 K | 466 K |
Accounts Payables |
820 K | 1.28 M | 1.37 M | 1.45 M | 2.42 M | 2.08 M | 2.65 M | 5.08 M | 3.59 M | 3.11 M | 2.77 M | - |
Accounts Receivables |
1.86 M | 733 K | 1.38 M | 1.28 M | 1.5 M | 1.69 M | 3.17 M | 5.13 M | 4.69 M | 4.9 M | 4.56 M | - |
Total Inventories |
3.33 M | 5.37 M | 5.88 M | 3.82 M | 4.49 M | 4.8 M | 3.59 M | 4.6 M | 5.61 M | 4.26 M | 6.29 M | - |
All numbers in USD currency
Quarterly Cash Flow ThermoGenesis Holdings
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-505 K | - | - | - | -615 K | - | -6.1 M | -5.1 M | -4.16 M | - | -6.29 M | -5.24 M | -3.95 M | - | -11.9 M | -8.95 M | -2.54 M | - | -3.52 M | -2.91 M | -2.44 M | - | -7.43 M | -6.1 M | -2.06 M | - | -1.45 M | -4.64 M | -2.54 M | - | -2.01 M | - | - | - | -1.3 M | -4.49 M | - | - | -3.68 M | - | - | - | -1.38 M | -4.33 M | - | - | -777 K | -2.5 M | -777 K | - | -1.52 M | -3.1 M | -1.52 M |
Depreciation & Amortization |
334 K | - | - | - | 267 K | - | 666 K | 410 K | 150 K | - | 477 K | 320 K | 166 K | - | 569 K | 392 K | 199 K | - | 202 K | 190 K | 206 K | - | 174 K | 174 K | 159 K | - | 160 K | 172 K | 160 K | - | 261 K | 473 K | 261 K | - | 365 K | 659 K | 365 K | 113 K | 322 K | 667 K | 322 K | - | 156 K | 327 K | 156 K | - | 134 K | 266 K | 134 K | - | 99 K | 202 K | 99 K |
Accounts Payables |
988 K | 948 K | 591 K | 508 K | 934 K | 820 K | 1.01 M | 1.24 M | 1.87 M | 1.28 M | 1.5 M | 1.12 M | 1.33 M | 1.37 M | 1.37 M | 1.37 M | 1.37 M | 1.45 M | 1.45 M | 1.45 M | 1.45 M | 2.42 M | 2.42 M | 2.42 M | 2.42 M | 2.08 M | 2.08 M | 2.08 M | 2.08 M | 2.06 M | 1.82 M | 2.65 M | 2.65 M | 4.42 M | 5.65 M | 5.08 M | 5.08 M | 3.17 M | 3.01 M | 3.59 M | 3.59 M | 2.74 M | 3.22 M | 3.11 M | 3.11 M | 1.4 M | 1.5 M | 2.77 M | 2.77 M | 1.65 M | 1.82 M | 1.79 M | 1.79 M |
Accounts Receivables |
1.15 M | 949 K | 368 K | 774 K | 955 K | 1.86 M | 2.06 M | 2.31 M | 2.18 M | 733 K | 2.57 M | 1.24 M | 826 K | 1.38 M | 1.38 M | 1.38 M | 1.38 M | 1.28 M | 1.28 M | 1.28 M | 1.28 M | 1.51 M | 1.51 M | 1.51 M | 1.51 M | 1.69 M | 1.69 M | 1.69 M | 1.69 M | 3.02 M | 3.01 M | 3.17 M | 3.17 M | 3.47 M | 3.65 M | 5.13 M | 5.13 M | 4.57 M | 4.37 M | 4.69 M | 4.69 M | 5.54 M | 4.21 M | 4.9 M | 4.9 M | 5.36 M | 3.52 M | 4.56 M | 4.56 M | 4.98 M | 4.41 M | 3.96 M | 3.96 M |
Total Inventories |
1.25 M | 1.41 M | 1.82 M | 2.66 M | 3.43 M | 3.33 M | 4.91 M | 5.49 M | 5.89 M | 5.37 M | 5.54 M | 5.81 M | 5.33 M | 5.88 M | 5.88 M | 5.88 M | 5.88 M | 3.48 M | 3.82 M | 3.82 M | 3.82 M | 4.49 M | 4.49 M | 4.49 M | 4.49 M | 4.8 M | 4.8 M | 4.8 M | 4.8 M | 2.76 M | 3.36 M | 3.59 M | 3.59 M | 3.99 M | 3.97 M | 4.6 M | 4.6 M | 5.2 M | 5.89 M | 5.61 M | 5.61 M | 4.18 M | 4.41 M | 4.26 M | 4.26 M | 5.35 M | 6.21 M | 6.29 M | 6.29 M | 6.79 M | 6.58 M | 6.35 M | 6.35 M |
All numbers in USD currency
Cash Flow Statement is one of the three key financial reports of the company ThermoGenesis Holdings, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.
Main Sections of the Cash Flow Statement- Operating Activities
This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash. - Investing Activities
Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign. - Financing Activities
Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.
The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.
Cash flow statements of other stocks in the Medical devices sector
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
$ 3.22 | -2.57 % | $ 121 M |  France |
 |
Align Technology
ALGN
|
$ 189.61 | -0.56 % | $ 14.2 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
- | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
$ 12.8 | 0.55 % | $ 1.73 B | USA |
 |
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | USA |
 |
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
- | - | $ 16.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
$ 2.16 | 4.85 % | $ 1.31 M | USA |
 |
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
$ 0.63 | -3.04 % | $ 39.2 M | USA |
 |
Apollo Endosurgery
APEN
|
- | - | $ 475 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
$ 16.19 | -0.12 % | $ 380 M | USA |
 |
ClearPoint Neuro
CLPT
|
$ 11.78 | 9.58 % | $ 334 M | USA |
 |
LivaNova PLC
LIVN
|
$ 64.2 | -1.45 % | $ 3.5 B |  Britain |
 |
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
- | - | $ 10.2 M | USA |
 |
Pulmonx Corporation
LUNG
|
$ 1.27 | -0.78 % | $ 51.7 M | USA |
 |
Electromed
ELMD
|
$ 26.39 | 3.57 % | $ 223 M | USA |
 |
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
- | -0.57 % | $ 7.12 M | USA |
 |
Neovasc
NVCN
|
- | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
$ 94.87 | 0.52 % | $ 12.8 B | USA |
 |
Orthofix Medical
OFIX
|
$ 12.35 | 1.65 % | $ 489 M |  Curacao |
 |
Butterfly Network
BFLY
|
$ 5.33 | 3.5 % | $ 1.13 B | USA |
 |
Delcath Systems
DCTH
|
$ 10.84 | 1.88 % | $ 388 M | USA |
 |
IRIDEX Corporation
IRIX
|
$ 1.06 | 0.95 % | $ 18 M | USA |
 |
Insulet Corporation
PODD
|
$ 189.56 | -1.38 % | $ 13.3 B | USA |
 |
CONMED Corporation
CNMD
|
$ 38.34 | 2.24 % | $ 1.19 B | USA |
 |
Inspire Medical Systems
INSP
|
$ 56.31 | -0.07 % | $ 1.65 B | USA |
 |
Integer Holdings Corporation
ITGR
|
$ 86.02 | 1.37 % | $ 2.99 B | USA |
 |
PAVmed
PAVM
|
$ 9.0 | -1.85 % | $ 6.03 M | USA |
 |
Invacare Corporation
IVC
|
- | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
$ 84.15 | 5.56 % | $ 49.2 B | USA |
 |
LENSAR
LNSR
|
$ 5.09 | -3.23 % | $ 60.9 M | USA |
 |
Sintx Technologies
SINT
|
$ 2.47 | -1.59 % | $ 6.85 M | USA |
 |
MiMedx Group
MDXG
|
$ 3.43 | 2.39 % | $ 507 M | USA |
 |
Stryker Corporation
SYK
|
$ 327.51 | -0.65 % | $ 125 B | USA |